The Effects of Removing the Requirement for Prior Reimbursement Approval on Anticoagulant Use in Ireland: A Cross‐Sectional Study
The removal of prior approval for reimbursement of DOACs in Ireland had a minimal impact on the prescribing frequency trends of the OACs. Future use of these potentially useful policies by healthcare systems requires careful consideration of drug type, approval criteria and length of time the policy remains in place to minimise any negative effects associated with their use.
Authors
- M. Scannell (ORCID: https://orcid.org/0000-0002-5501-6451)
- Edel Burton (ORCID: https://orcid.org/0000-0002-5847-0174)
- Patricia M. Kearney (ORCID: https://orcid.org/0000-0001-9599-3540)
Institutions
- University College Cork (IE)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1002/pds.70011
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Irish Research eLibrary